Literature DB >> 28462854

Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals.

Mohamed H Al-Agamy1, Abduelah Aljallal2, Hesham H Radwan2, Atef M Shibl3.   

Abstract

The main objective of this work was to characterize carbapenemases, extended-spectrum β-lactamases (ESBLs), and plasmid-mediated quinolone resistance (PMQR) among carbapenem-insensitive Klebsiella pneumoniae and Escherichia coli clinical isolates which were isolated from three hospitals in Riyadh. Thirty-one carbapenem-insensitive isolates (21 K. pneumoniae and 10 E. coli) were recovered from March 2014 to May 2014. Susceptibility testing and phenotypic detection tests were used to characterize the classes of β-lactamases. PCR assays were performed for the detection of the genes encoding ESBL (blaCTX-M, blaTEM,blaSHV, and blaOXA-1), carbapenemase (blaKPC,blaGES,blaVIM, blaIMP, blaNDM, and blaOXA-48), and PMQR (qnrA, qnrB, qnrS, aac(6)-Ib-cr, qepA, oqxA, and oqxB) genes. All carbapenem-insensitive isolates were carbapenemase producers, with 41.9% and 58.1% being class B carbapenemases class D OXA-48, respectively. While the prevalence of ESBL producers was 80.6%. The following resistance genes were detected; OXA-48-like (58.1%), NDM-type (41.9%), CTX-M-1-like (77.4%), CTX-M-9-like (9.6%), TEM-1 (74.2%), OXA-1 (54.8%), SHV-1 (4.4%), qnrS (58.1%), qnrB (3.2%), and aac(6)-Ib-cr (51.6%). The predominant carbapenemases in the isolates that had carbapenem MIC≤4μg/ml and MIC≥12μg/ml were blaOXA-48-type and blaNDM-type respectively. CTX-M-1-like and qnrS were the dominant ESBL and PMQR genes, respectively. This is the first report in which qnrS was described in the isolates from Saudi Arabia.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Carbapenem resistance; NDM; OXA-48; Saudi Arabia

Mesh:

Substances:

Year:  2017        PMID: 28462854     DOI: 10.1016/j.jiph.2017.03.010

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  17 in total

Review 1.  Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline.

Authors:  Sara E Boyd; David M Livermore; David C Hooper; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  The first evaluation relationship of integron genes and the multidrug-resistance in class A ESBLs genes in enteropathogenic Escherichia coli strains isolated from children with diarrhea in Southwestern Iran.

Authors:  Nabi Jomehzadeh; Khadijeh Ahmadi; Hazhir Javaherizadeh; Maryam Afzali
Journal:  Mol Biol Rep       Date:  2020-12-14       Impact factor: 2.316

3.  Investigation of plasmid-mediated resistance in E. coli isolated from healthy and diarrheic sheep and goats.

Authors:  I I Shabana; A T Al-Enazi
Journal:  Saudi J Biol Sci       Date:  2020-01-16       Impact factor: 4.219

Review 4.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

5.  Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia.

Authors:  Moataz Abd El Ghany; Hazem Sharaf; Mohamed H Al-Agamy; Atef Shibl; Grant A Hill-Cawthorne; Pei-Ying Hong
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

6.  Microbial virulence, molecular epidemiology and pathogenic factors of fluoroquinolone-resistant Haemophilus influenzae infections in Guangzhou, China.

Authors:  Dingqiang Chen; Shuxian Wen; Donghua Feng; Ruirui Xu; Junyan Liu; Brian M Peters; Danhong Su; Yongping Lin; Ling Yang; Zhenbo Xu; Mark E Shirtliff
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-11-23       Impact factor: 3.944

7.  Prevalence of quinolone-resistant uropathogenic Escherichia coli in a tertiary care hospital in south Iran.

Authors:  Yalda Malekzadegan; Elham Rastegar; Melika Moradi; Hamid Heidari; Hadi Sedigh Ebrahim-Saraie
Journal:  Infect Drug Resist       Date:  2019-06-19       Impact factor: 4.003

8.  Cooccurrence of NDM-1, ESBL, RmtC, AAC(6')-Ib, and QnrB in Clonally Related Klebsiella pneumoniae Isolates Together with Coexistence of CMY-4 and AAC(6')-Ib in Enterobacter cloacae Isolates from Saudi Arabia.

Authors:  Mohamed H Al-Agamy; Taghrid S El-Mahdy; Hesham H Radwan; Laurent Poirel
Journal:  Biomed Res Int       Date:  2019-07-29       Impact factor: 3.246

9.  Comparative Genomics of Escherichia coli Sequence Type 219 Clones From the Same Patient: Evolution of the IncI1 blaCMY-Carrying Plasmid in Vivo.

Authors:  Cheng-Yen Kao; Jenn-Wei Chen; Tsung-Lin Liu; Jing-Jou Yan; Jiunn-Jong Wu
Journal:  Front Microbiol       Date:  2018-07-09       Impact factor: 5.640

10.  Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia.

Authors:  Muhammad Yasir; Abeer M Ajlan; Shazi Shakil; Asif A Jiman-Fatani; Saad B Almasaudi; Muhammad Farman; Zainah M Baazeem; Rnda Baabdullah; Maha Alawi; Nabeela Al-Abdullah; Nashat A Ismaeel; Hani A Shukri; Esam I Azhar
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.